Literature DB >> 1553350

Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic.

C E Pasini1, J M Indelicato.   

Abstract

Loracarbef is an oral 1-carba-1-dethiacephalosporin antibiotic structurally related to cefaclor. Like many beta-lactam antibiotics, loracarbef exists in several hydrated crystalline forms. The pH-solubility profile curve for loracarbef monohydrate is U-shaped, resembling those of other zwitterionic cephalosporins. Loracarbef was found to be much more stable in solution than cefaclor. For example, in pH 7.4 phosphate buffer, loracarbef was unexpectedly found to be 130-150 times more stable than cefaclor and 10-12 times more stable than cephalexin, depending on the phosphate concentration. The pH-stability profile is U-shaped, similar to that of other zwitterionic cephalosporins, and shows maximum stability at the isoelectric point. At any given pH, loracarbef is more stable in solution than any other therapeutically useful cephalosporin. Acetate, borate, citrate, and especially phosphate buffers have catalytic effects on the rate of loracarbef hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1553350     DOI: 10.1023/a:1018949709797

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Comparative reactivity of 1-carba-1-dethiacephalosporins with cephalosporins.

Authors:  L C Blaszczak; R F Brown; G K Cook; W J Hornback; R C Hoying; J M Indelicato; C L Jordan; A S Katner; M D Kinnick; J H McDonald
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

2.  Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins.

Authors:  J H Jorgensen; J S Redding; L A Maher
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

3.  Degradation kinetics of a new cephalosporin derivative in aqueous solution.

Authors:  E S Rattie; J J Zimmerman; L J Ravin
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

4.  Substituent effects in cephalosporins as assessed by molecular orbital calculations, nuclear magnetic resonance, and kinetics.

Authors:  D B Boyd
Journal:  J Med Chem       Date:  1983-07       Impact factor: 7.446

5.  Comparative stability of cephalosporins in aqueous solution: kinetics and mechanisms of degradation.

Authors:  T Yamana; A Tsuji
Journal:  J Pharm Sci       Date:  1976-11       Impact factor: 3.534

6.  The acylating potential of gamma-lactam antibacterials: base hydrolysis of bicyclic pyrazolidinones.

Authors:  J M Indelicato; C E Pasini
Journal:  J Med Chem       Date:  1988-06       Impact factor: 7.446

7.  Synthesis and substituent effects on antibacterial activity, alkaline hydrolysis rates, and infrared absorption frequencies of some cephem analogues related to latamoxef (moxalactam).

Authors:  M Narisada; T Yoshida; M Ohtani; K Ezumi; M Takasuka
Journal:  J Med Chem       Date:  1983-11       Impact factor: 7.446

8.  Kinetics and mechanism of degradation of cefotaxime sodium in aqueous solution.

Authors:  S M Berge; N L Henderson; M J Frank
Journal:  J Pharm Sci       Date:  1983-01       Impact factor: 3.534

9.  Degradation kinetics and mechanism of aminocephalosporins in aqueous solution: cefadroxil.

Authors:  A Tsuji; E Nakashima; Y Deguchi; K Nishide; T Shimizu; S Horiuchi; K Ishikawa; T Yamana
Journal:  J Pharm Sci       Date:  1981-10       Impact factor: 3.534

10.  Intramolecular nucleophilic amino attack in a monobactam: synthesis and stability of (2S,3S)- 3-[(2R)-2-amino-2-phenylacetamido]-2-methyl-4-oxo-1- azetidinesulfo nic acid.

Authors:  J M Indelicato; J W Fisher; C E Pasini
Journal:  J Pharm Sci       Date:  1986-03       Impact factor: 3.534

View more
  2 in total

1.  The effect of four different types of diet on the bioavailability of loracarbef.

Authors:  A T Bapujee; T Singh; T Ahmed; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

Review 2.  Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; D McTavish
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.